Elevated MMP-2, MMP-9, and NLRP3 levels in Past PTSD (≤5 y) imply ongoing neuroinflammation and synaptic remodeling, while reduced GABA levels indicate disrupted inhibitory signaling, potentially contributing to symptom severity. This evidence concerns the gene MMP9 and post-traumatic stress disorder.